Add less water, get a higher concentration
El nuevo anlisis de subconjuntos encontr que las personas en el ensayo FLOW que recibieron semaglutida en la dosis de 1 mg tenan probabilidades ms bajas de insuficiencia cardaca de nueva aparicin u hospitalizacin por insuficiencia cardaca, en comparacin con las que recibieron la inyeccin de placebo
3,4 In fact, one study found that hair thinning was reported in almost 7% of people taking high-dose oral semaglutide, compared to less than 1% on placebo
GLP-1 receptor agonists enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, slow gastric emptying, and promote satiety through central nervous system pathways
Genetic predisposition in peptide signaling pathways can also provide context for how individual patients metabolize and respond to GLP-1 medications, supporting more tailored clinical decisions
Southern Primary Care offers a physician-supervised program that can identify and treat underlying health conditions affecting your weight, prescribe FDA-approved medications when appropriate, and provide coordinated care across diet, exercise, and medical management
